A detailed history of Advisors Preferred, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Advisors Preferred, LLC holds 4,555 shares of CNTA stock, worth $76,979. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,555
Holding current value
$76,979
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$8.58 - $16.99 $39,081 - $77,389
4,555 New
4,555 $72,000
Q1 2024

May 08, 2024

BUY
$6.73 - $12.2 $12,282 - $22,265
1,825 New
1,825 $20,000

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.59B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Advisors Preferred, LLC Portfolio

Follow Advisors Preferred, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Preferred, LLC with notifications on news.